Efficacy and Safety of Filgotinib as Induction and Maintenance Therapy for Crohn's Disease: Results From the Phase 3 Randomized, Double-Blind, Placebo-Controlled DIVERSITY1 Study

被引：0
|
作者：
Vermeire, Severine [1 ]
Rubin, David T. [2 ]
Watanabe, Mamoru [3 ]
Schreiber, Stefan [4 ]
Mehta, Rajiv [5 ]
Roblin, Xavier [6 ]
Genovese, Mark C. [7 ]
Masior, Tomasz [8 ]
Barron, Rahul [8 ]
Le Brun, Franck-Olivier [8 ]
Danese, Silvio [9 ]
机构：
[1] Univ Ziekenhuis Leuven, Leuven, Vlaams Brabant, Belgium
[2] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[3] Tokyo Med & Dent Univ, Adv Res Inst, Tokyo, Japan
[4] Univ Hosp Schleswig Holstein, Kiel, Schleswig Holst, Germany
[5] Digest Sci Hosp, Surat Inst, Surat, Gujarat, India
[6] Univ Hosp St Etienne, St Etienne, Pays De La Loir, France
[7] Gilead Sci Inc, Foster City, CA USA
[8] Galapagos GmbH, Basel, Basel Stadt, Switzerland
[9] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Lombardia, Italy
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S904
引用
收藏
页码：S673 / S675
页数：3
相关论文
共 50 条
  • [1] Vedolizumab Induction Therapy for Crohn's Disease: Results of Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
    Sandborn, William
    Sands, Bruce
    Colombel, Jean-Frederic
    Feagan, Brian
    Hanauer, Stephen
    Rutgeerts, Paul
    Lukas, Milan
    Fedorak, Richard
    Lee, Scott
    Bressler, Brian
    Xu, Jing
    Sankoh, Serap
    Stephens, Kristin
    Parikh, Asit
    Fox, Irving
    Milch, Catherine
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S624 - S625
  • [2] Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjogren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study
    Price, Elizabeth
    Bombardieri, Michele
    Kivitz, Alan
    Matzkies, Franziska
    Gurtovaya, Oksana
    Pechonkina, Alena
    Jiang, Wendy
    Downie, Bryan
    Mathur, Anubhav
    Mozaffarian, Afsaneh
    Mozaffarian, Neelufar
    Gottenberg, J. Eric
    [J]. RHEUMATOLOGY, 2022, 61 (12) : 4797 - 4808
  • [3] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
  • [4] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [5] Vedolizumab Maintenance Therapy for Crohn's Disease: Results of GEMINI II, a Randomized, Placebo-Controlled, Double-Blind, Multi-center Phase 3 Trial
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Feagan, Brian
    Rutgeerts, Paul
    Sandborn, William
    Sands, Bruce
    Lukas, Milan
    Fedorak, Richard
    Lee, Scott
    Bressler, Brian
    Fox, Irving
    Xu, Jing
    Sankoh, Serap
    Stephens, Kristin
    Milch, Catherine
    Parikh, Asit
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S620 - S621
  • [6] A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease
    Sutherland, LR
    Martin, F
    Bailey, RJ
    Fedorak, RN
    Poleski, M
    Dallaire, C
    Rossman, R
    Saibil, F
    Lariviere, L
    Meyer, D
    Baker, SJ
    Alvi, AW
    Bass, S
    Blustein, PK
    Bridges, RJ
    Lay, TE
    vanRosendaal, GMA
    Watson, MH
    Clermont, R
    Cockeram, AW
    Mabey, M
    DaCosta, L
    Beck, IT
    Depew, W
    Groll, A
    Paterson, W
    Simon, J
    Vanner, S
    DAmore, D
    Sherbaniuk, R
    Cherry, R
    Lalor, E
    Thomson, ABR
    Yacyshyn, B
    Bain, V
    Fisher, D
    Kirdeikis, P
    Halle, P
    Irvine, EJ
    Collins, SM
    Croitoru, K
    Crowe, SE
    Goodacre, RL
    Hunt, RH
    Sabena, BJ
    Donnelly, M
    Khan, MAR
    Langevin, S
    Menard, DB
    Haddad, H
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : 1069 - 1077
  • [7] A Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Ustekinumab Maintenance Therapy in Moderate - Severe Crohn's Disease Patients: Results From IM-UNITI
    Sandborn, William
    Feagan, Brian G.
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean-Frederic
    Lee, Scott
    Dieleman, Levinus A.
    Katz, Seymour
    Rutgeerts, Paul J.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S157 - S158
  • [8] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    [J]. JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [9] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    [J]. GASTROENTEROLOGY, 2021, 160 (03) : S1 - S2
  • [10] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 : S1 - S1
12345